aap Implantate Divests Biomaterials Unit

Update 5/11/16: The buyer is Keensight Capital.

aap Implantate sold its biomaterials unit to an undisclosed private equity firm in the EU for €36MM (~US $40.3MM). For 2015, the unit achieved revenue of ~US $17.9MM. Upon closing, which is slated for 2Q16, aap will proceed as a pure-play trauma entity.

Source: aap Implantate...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us